ArticleCureus2024
A Recurrent Case of Papillary Eccrine Adenoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papillary eccrine adenoma (PEA) is a rare benign eccrine gland neoplasm presenting as a solitary nodule, primarily in middle-aged African American females. Accurate histological diagnosis is crucial due to its potential to mimic adnexal carcinomas. Complete excision is recommended due to its risk of local aggression and recurrence. A 75-year-old Caucasian male with a history of basal cell carcinoma (BCC) presented with a recurrent pink, scaly nodule on the right medial pretibial leg area. Initial biopsy showed benign PEA. The lesion recurred after one year, and a re-biopsy confirmed a tubulopapillary adenoma within a scar. The lesion was excised with a 2 mm margin. PEA is characterized histologically by dilated ducts lined by a dual layer of tumor cells, often with intraluminal papillae structures. Immunohistochemical staining aids diagnosis, with markers such as S-100, carcinoembryonic antigen (CEA), and epithelial membrane antigen (EMA) indicating eccrine differentiation. Differential diagnoses include adnexal carcinomas and BCC with eccrine differentiation. Complete excision is necessary to prevent recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.